Restructuring

6 Months Ended

Jun. 30, 2020

Restructuring and Related Activities [Abstract]

RESTRUCTURING

In accordance with the applicable guidance for ASC 712, Nonretirement Postemployment Benefits, we accounted for termination benefits and recognized liabilities when the loss was considered probable that employees were entitled to benefits and the amounts could be reasonably estimated.

We have incurred costs in connection with involuntary termination benefits associated with our corporate-related initiatives and cost-saving opportunities associated with our Axalta Way initiatives. During the three and six months ended June 30, 2020 and 2019, we incurred restructuring costs, net of changes to estimates, of $13.7 million, $32.2 million, $2.9 million and $4.2 million, respectively. These amounts are recorded within other operating charges in the condensed consolidated statements of operations. The remaining payments associated with these actions are expected to be substantially completed within 18 months.

The following table summarizes the activities related to the restructuring reserves and expenses from December 31, 2019 to June 30, 2020:



	2020 Activity
Balance at December 31, 2019	$	78.0
Expenses, net of changes to estimates	32.2
Payments made	(37.9		)
Foreign currency translation	0.1
Balance at June 30, 2020	$	72.4

We recognized impairments of $2.7 million and $3.2 million during the three and six months ended June 30, 2020, respectively, primarily attributable to impairments and associated write-downs resulting from our recent decision to exit the Performance Coatings segment business in Argentina. The impairments are included in the condensed consolidated statements of operations within other operating charges.

The impacts to pre-tax earnings from incremental accelerated depreciation resulting from the previously announced closure of our manufacturing facility in Mechelen, Belgium for the three and six months ended June 30, 2020 and 2019 were $0.4 million, $8.5 million, $6.7 million and $12.8 million, respectively, which were recorded to cost of goods sold on the condensed consolidated statements of operations.